种族和族裔与美国肾脏分配系统下高寿命 deceased donor 肾移植的关联
该观察性队列研究基于2015至2020年SRTR数据,纳入199444名成人肾移植候选者,评估种族和族裔与EPTS≤20%及接受KDPI≤20%肾脏移植的关联。研究发现亚裔、黑人和西班牙裔候选者年龄校正后EPTS≤20%的几率及接受高寿命肾脏的可能性均显著低于白人,但移植后生存率相似或更优。结论提示美国肾脏分配系统可能通过EPTS标准加剧种族差异。
要点
- 非白人候选者糖尿病比例更高、透析时间更长且更年轻。
- 年龄校正后,亚裔、黑人和西班牙裔候选者EPTS≤20%的几率显著低于白人。
- 这些少数族裔接受KDPI≤20%肾脏的可能性也显著更低。
核心结论
- 美国肾脏分配系统较少将种族和族裔少数候选者识别为EPTS≤20%,从而影响高寿命肾脏的分配。
主要发现
- 亚裔、黑人和西班牙裔候选者年龄校正后EPTS≤20%的比值比分别为0.86(95%CI 0.81-0.91)、0.52(95%CI 0.50-0.54)和0.49(95%CI 0.47-0.51)。
- 亚裔、黑人和西班牙裔候选者接受KDPI≤20%肾脏的亚风险比分别为0.70(95%CI 0.66-0.75)、0.89(95%CI 0.87-0.92)和0.73(95%CI 0.71-0.76)。
- 在EPTS≤20%且接受KDPI≤20%肾脏的受者中,亚裔和西班牙裔移植后死亡风险低于白人(HR分别为0.45 [95%CI 0.27-0.77]和0.63 [95%CI 0.47-0.86]),黑人死亡风险更高但无统计学意义(HR 1.22 [95%CI 0.99-1.52])。
临床怎么用
- 临床医生应意识到当前EPTS标准可能使少数族裔候选者处于不利地位。
- 在等待名单管理和移植评估中,需关注种族差异对高寿命肾脏分配的影响。
局限性
- 种族和族裔数据由提供者报告,可能存在分类偏差。
- 移植后随访时间仅5年。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: The US Kidney Allocation System (KAS) prioritizes candidates with a≤20% estimated posttransplant survival (EPTS) to receive high-longevity kidneys defined by a≤20% Kidney Donor Profile Index (KDPI). Use of EPTS in the KAS deprioritizes candidates with older age, diabetes, and longer dialysis durations. We assessed whether this use also disadvantages race and ethnicity minority candidates, who are younger but more likely to have diabetes and longer durations of kidney failure requiring dialysis. STUDY DESIGN: Observational cohort study. SETTING & PARTICIPANTS: Adult candidates for and recipients of kidney transplantation represented in the Scientific Registry of Transplant Recipients from January 2015 through December 2020. EXPOSURE: Race and ethnicity. OUTCOME: Age-adjusted assignment to≤20% EPTS, transplantation of a≤20% KDPI kidney, and posttransplant survival in longevity-matched recipients by race and ethnicity. ANALYTIC APPROACH: Multivariable logistic regression, Fine-Gray competing risks survival analysis, and Kaplan-Meier and Cox proportional hazards methods. RESULTS: The cohort included 199,444 candidates (7% Asian, 29% Black, 19% Hispanic or Latino, and 43% White) listed for deceased donor kidney transplantation. Non-White candidates had significantly higher rates of diabetes, longer dialysis duration, and were younger than White candidates. Adjusted for age, Asian, Black, and Hispanic or Latino candidates had significantly lower odds of having a ETPS score of≤20% (odds ratio, 0.86 [95% CI, 0.81-0.91], 0.52 [95% CI, 0.50-0.54], and 0.49 [95% CI, 0.47-0.51]), and were less likely to receive a≤20% KDPI kidney (sub-hazard ratio, 0.70 [0.66-0.75], 0.89 [0.87-0.92], and 0.73 [0.71-0.76]) compared with White candidates. Among recipients with≤20% EPTS scores transplanted with a≤20% KDPI deceased donor kidney, Asian and Hispanic recipients had lower posttransplant mortality (HR, 0.45 [0.27-0.77] and 0.63 [0.47-0.86], respectively) and Black recipients had higher but not statistically significant posttransplant mortality (HR, 1.22 [0.99-1.52]) compared with White recipients. LIMITATIONS: Provider reported race and ethnicity data and 5-year post transplant follow-up period. CONCLUSIONS: The US kidney allocation system is less likely to identify race and ethnicity minority candidates as having a≤20% EPTS score, which triggers allocation of high-longevity deceased donor kidneys. These findings should inform the Organ Procurement and Transplant Network about how to remedy the race and ethnicity disparities introduced through KAS's current approach of allocating allografts with longer predicted longevity to recipients with longer estimated posttransplant survival. PLAIN-LANGUAGE SUMMARY: The US Kidney Allocation System prioritizes giving high-longevity, high-quality kidneys to patients on the waiting list who have a high estimated posttransplant survival (EPTS) score. EPTS is calculated based on the patient's age, whether the patient has diabetes, whether the patient has a history of organ transplantation, and the number of years spent on dialysis. Our analyses show that Asian, Black or African American, and Hispanic or Latino patients were less likely to receive high-longevity kidneys compared with White patients, despite having similar or better posttransplant survival outcomes.
引用
- Asfour NW, Zhang KC, Lu J, et al. Association of Race and Ethnicity With High Longevity Deceased Donor Kidney Transplantation Under the US Kidney Allocation System. Am J Kidney Dis. 2024. PMID: 38636649. doi:10.1053/j.ajkd.2024.02.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。